NKp80 Defines a Critical Step during Human Natural Killer Cell Development
2016 · Cell Reports · 115 citations
https://doi.org/10.1016/j.celrep.2016.05.095
A
Aharon G. Freud
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
167
Papers
6.7K
Citations
41
h-index
68
i10-index
Aharon G. Freud is an academic researcher from The Ohio State University. The author has contributed to research in topics: Immune Cell Function and Interaction & IL-33, ST2, and ILC Pathways & T-cell and B-cell Immunology. The author has an h-index of 41, co-authored 142 publications.
ORCID: 0000-0001-6086-1521Papers by this author
worksIL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB
2017 · The Journal of Immunology · 95 citations
https://doi.org/10.4049/jimmunol.1601554
The Transcription Factor AHR Prevents the Differentiation of a Stage 3 Innate Lymphoid Cell Subset to Natural Killer Cells
2014 · Cell Reports · 91 citations
https://doi.org/10.1016/j.celrep.2014.05.042
CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas
2012 · American Journal Of Pathology · 51 citations
https://doi.org/10.1016/j.ajpath.2012.05.015
Gut dysbiosis is associated with acceleration of lupus nephritis
2022 · Scientific Reports · 38 citations
https://doi.org/10.1038/s41598-021-03886-5
Aiolos represses CD4+ T cell cytotoxic programming via reciprocal regulation of TFH transcription factors and IL-2 sensitivity
2023 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-023-37420-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat